Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009

Research in Microbiology

Volumn 161, Issue 10, 2010, Pages 810-815

  Kurova, Natalia ^a   Njamkepo, Elisabeth ^b   Brun, Delphine ^b   Tseneva, Galina ^a   Guiso, Nicole ^b  

^a ST PETERSBURG PASTEUR INSTITUTE   (Russian Federation)

^b CNRS   (France)

Author keywords

Bordetella parapertussis isolates; Bordetella pertussis; St Petersburg; Whooping cough

Indexed keywords

BORDETELLA VIRULENCE FACTOR; PERTUSSIS VACCINE;

ARTICLE; BACTERIUM ISOLATE; BORDETELLA PARAPERTUSSIS; BORDETELLA PARAPERTUSSIS INFECTION; BORDETELLA PERTUSSIS; DISEASE SURVEILLANCE; GENE SEQUENCE; HUMAN; IMMUNOBLOTTING; IMMUNOGENICITY; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RUSSIAN FEDERATION; SEROTYPING;

BACTERIAL TYPING TECHNIQUES; BORDETELLA INFECTIONS; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; IMMUNOBLOTTING; INCIDENCE; INFANT; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; RUSSIA; SEQUENCE ANALYSIS, DNA; SEROTYPING; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); BORDETELLA; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS;

EID: 78649946371     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2010.09.013     Document Type: Article

References (30)

1. Bouchez V., Brun D., Cantinelli T., Dore G., Njamkepo E., Guiso N. First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine 2009, 27:6034-6041.
2. Bouchez V., Caro V., Levillain E., Guigon G., Guiso N. Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS ONE 2008, 3(6). e2437.
3. Caro V., Elomaa A., Brun D., Mertsola J., He Q., Guiso N. Bordetella pertussis, Finland and France. Emerging Infect. Dis. 2006, 12(6):987-989.
4. Caro V., Hot D., Guigon G., Hubans C., Arrive M., Soubigou G., Renauld-Mongenie G., Antoine R., Locht C., Lemoine Y., Guiso N. Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization Bordetella pertussis, Finland and France. Microbes Infect. 2006, 8(8):2228-2235.
5. Caro V., Njamkepo E., Van Amersfoorth S.C., Mooi F.R., Advani A., Hallander H.O., He Q., Mertsola J., Riffelmann M., Vahrenholz C., Von Konig C.H., Guiso N. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect. 2005, 7(7-8):976-982.
6. Chenal-Francisque V., Caro V., Boursaux-Eude C., Guiso N. Genomic analysis of the adenylate cyclase-hemolysin C-terminal region of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Res. Microbiol. 2009, 160(5):330-336.
7. Grimprel E., Baron S., Levy-Bruhl D., Garnier J.M., Njamkepo E., Guiso N., Bégué P. Influence of vaccination coverage on pertussis transmission in France. Lancet 1999, 354(9191):1699-1700.
8. Guiso N. Bordetella pertussis and pertussis vaccines. Clin. Infect. Dis. 2009, 49(10):1565-1569.
9. Guiso N., von Konig C.H.W., Becker C., Hallander H. Fimbrial typing of Bordetella pertussis isolates: agglutination with polyclonal and monoclonal antisera. J. Clin. Microbiol. 2001, 39(4):1684-1685.
10. He Q., Mertsola J. Factors contributing to pertussis resurgence. Future Microbiol. 2008, 3:329-339.
11. He Q.S., Viljanen M.K., Arvilommi H., Aittanen B., Mertsola J. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 1998, 280(7):635-637.
12. Heininger U., Stehr K., Christenson P., Cherry J.D. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine hot not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection. Clin. Infect. Dis. 1999, 28(3):602-604.
13. Kallonen T., He Q. Bordetella pertussis strain variation and evolution postvaccination. Expert Rev. Vaccines 2009, 8(7):863-875.
14. Khelef N., Danve B., Quentin-Millet M.J., Guiso N. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect. Immun. 1993, 61:486-490.
15. King A.J., van Gorkom T., Pennings J.L., van der Heide H.G., He Q., Diavatopoulos D., Heuvelman K., van Gent M., van Leeuwen K., Mooi F.R. Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMC Genomics 2008, 9(1):311.
16. Kourova N., Caro V., Weber C., Thiberge S., Chuprinina R., Tseneva G., Guiso N. Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains. J. Clin. Microbiol. 2003, 41(8):3706-3711.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
18. Lautrop H. Epidemics of parapertussis. 20 years' observations in Denmark. Lancet 1971, 1195-1197. (12 June).
19. Mattoo S., Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 2005, 18(2):326-382.
20. Mooi F.R., Hallander H., Wirsing von Köning C.H., Hoet B., Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. Clin. Infect. Dis. J. 2000, 19:174-181.
21. Mooi F.R., He Q., Guiso N. Phylogeny, evolution, and epidemiology of Bordetellae. Bordetella: Molecular Microbiology 2007, 17-45. INSERM U629 and Institut Pasteur de Lille, Horizon Bioscience, Norfolk, United Kingdom. F. Camille Locht (Ed.).
22. Njamkepo E., Cantinelli T., Guigon G., Guiso N. Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas. Microbes Infect. 2008, 10(14-15):1582-1586.
23. Relyveld E., Oato N.H., Guerin N., Coursaget P., Huet M., Gupta R.K. Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal. Vaccine 1991, 9(11):843-850.
24. Restif O., Wolfe D.N., Goebel E.M., Bjornstad O.N., Harvill E.T. Of mice and men: asymmetric interactions between Bordetella pathogen species. Parasitology 2008, 135(13):1517-1529.
25. Saitou N., Nei M. A new method for reconstructing phylogenetic tree. Mol. Biol. Evol. 1987, 4:406-425.
26. Simondon F., Iteman I., Preziosi M.P., Yam A., Guiso N. Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal. Clin. Diagn. Lab. Immunol. 1998, 5(2):130-134.
27. Simondon F., Preziosi M.P., Yam A., Kane C.T., Chabirand L., Iteman I., Sanden G., Mboup S., Hoffenbach A., Knudsen K., Guiso N., Wassilak S., Cadoz M. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 1997, 15(15):1606-1612.
28. Watanabe M., Nagai M. Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev. Anti Infect. Ther. 2004, 2(3):447-454.
29. Wendelboe A.M., Njamkepo E., Bourillon A., Floret D.D., Gaudelus J., Gerber M., Grimprel E., Greenberg D., Halperin S., Liese J., Munoz-Rivas F., Teyssou R., Guiso N., Van Rie A. Transmission of Bordetella pertussis to young infants. Pediatr. Infect. Dis. J. 2007, 26(4):293-299.
30. Wirsing vonKonig C.H., Halperin S., Riffelmann M., Guiso N. Pertussis of adults and infants. Lancet Infect. Dis. 2002, 2(12):744-750.